Bicocca Open Archive

Logo unimib boa
VETTORETTI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 300
NA - Nord America 148
EU - Europa 117
AF - Africa 1
SA - Sud America 1
Totale 567
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 197
US - Stati Uniti d'America 134
SG - Singapore 72
DE - Germania 60
CN - Cina 28
IT - Italia 19
MX - Messico 11
NL - Olanda 11
FI - Finlandia 4
FR - Francia 4
GB - Regno Unito 4
UA - Ucraina 4
RU - Federazione Russa 3
SE - Svezia 3
AT - Austria 2
CA - Canada 2
IE - Irlanda 2
MM - Myanmar 2
AR - Argentina 1
HU - Ungheria 1
LK - Sri Lanka 1
PA - Panama 1
ZA - Sudafrica 1
Totale 567
Salva come PNG Salva come JPEG
Città #
Hong Kong 197
Frankfurt am Main 43
Ann Arbor 37
Singapore 29
Ashburn 14
Mexico City 10
Wenzhou 10
Xiamen 10
Seattle 8
Chandler 7
Buffalo 6
Cambridge 6
Fairfield 6
Ningbo 6
Santa Clara 6
Haarlem 5
Wilmington 5
Düsseldorf 4
Milan 4
New York 4
Woodbridge 4
Amsterdam 3
Helsinki 3
Mazara del Vallo 3
Boydton 2
Bronte 2
Dublin 2
Houston 2
Lauterbourg 2
Nuremberg 2
Parma 2
Princeton 2
Slough 2
Yangon 2
Cinisello Balsamo 1
Colombo 1
Croydon 1
Halifax 1
Lawrence 1
London 1
Monza 1
Phoenix 1
Rome 1
Río Cuarto 1
Sopron 1
Wuhan 1
Totale 462
Salva come PNG Salva come JPEG
Nome #
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 186
Vulvar pyoderma gangrenosum with renal involvement 16
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 15
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 15
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy (Journal of Nephrology, (2023), 36, 7, (2013-2022), 10.1007/s40620-023-01708-7) 15
What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives 15
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 15
Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction 14
Economic evaluation of angiotensin receptor blockers in type 2 diabetes, hypertension, and nephropathy 14
Plasma adiponectin levels in chronic kidney disease patients: Relation with molecular inflammatory profile and metabolic status 14
Endothelial dysfunction in chronic kidney disease: Determinant of susceptibility to end-organ damage and therapeutic response 13
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 12
Pulse pressure and subclinical cardiovascular damage in primary hypertension 11
Frailty Is Associated with Malnutrition–Inflammation Syndrome in Older CKD Patients 10
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 9
Microalbuminuria, cardiovascular, and renal risk in primary hypertension 9
Clinical Factors and Biomarkers Associated with Depressive Disorders in Older Patients Affected by Chronic Kidney Disease (CKD): Does the Advanced Glycation End Products (AGEs)/RAGE (Receptor for AGEs) System Play Any Role? 8
Palliative and Supportive Dialysis: Current Practices and Recommendations for Best Clinical Practice 8
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: An Italian multicenter prospective study 8
Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease 8
Relationship between number of daily exchanges at CAPD start with clinical outcomes 8
Serum uric acid and target organ damage in primary hypertension 8
What's New in the CKD-BMD Therapy? 8
Peritoneal dialysis related peritonitis: insights from a long-term analysis of an Italian center 8
Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation 8
Spontaneous low-protein intake in older CKD patients: one diet may not fit all 7
Can Mediterranean Diet Have a Positive Impact on Kidney Health? A Pending Answer to a Long-Time Question 7
The role of angiotensin II AT1 receptor antagonists in nephroprotection and cardioprotection in type 2 diabetes mellitus 7
Creatinine clearance and signs of end-organ damage in primary hypertension 7
Corrigendum: Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study (Frontiers in Medicine, (2023), 10, (1221086), 10.3389/fmed.2023.1221086) 7
Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats 7
Vitamin D and subclinical cardiac damage in a cohort of kidney transplanted patients: a retrospective observational study 7
Mild renal dysfunction and renal vascular resistance in primary hypertension 7
Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study 7
Optimizing global risk evaluation in primary hypertension: The role of microalbuminuria and cardiovascular ultrasonography 7
Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease 7
Cardiovascular and Renal Risk Assessment as a Guide for Treatment in Primary Hypertension 7
Poor Nutritional Status Is Associated with Death in a Population of Dialyzed Older Persons 7
Treatment of hyperuricemia in CKD 7
Palliative and supportive dialysis: State of the art and recommendations for good clinical practice 7
MCP1 Inverts the Correlation between FGF23 and Omega 6/3 Ratio: Is It Also True in Renal Transplantation? 7
Simultaneous removal and replacement of the peritoneal catheter in CAPD patient with refractory peritonitis sustained by P. aeruginosa: A case-report 7
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: An artificial neural network-based approach 7
Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension 7
Frailty phenotype and multi-domain impairments in older patients with chronic kidney disease 7
Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study 7
Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation 7
Association between the uremic toxins indoxyl-sulfate and p-cresyl-sulfate with sarcopenia and malnutrition in elderly patients with advanced chronic kidney disease 6
Metabolic acidosis in renal transplantation: neglected but of potential clinical relevance 6
Use of the Frailty Index in Older Persons With Chronic Kidney Disease 6
Patients with Hypertensive Nephropathy and Chronic Kidney Disease Might Not Benefit from Strict Blood Pressure Control 6
Is there an association between severity of illness and psychiatric symptoms in patients with chronic renal failure? 6
Beyond cohort selection: An analytics-enabled i2b2 6
Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial 6
In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition 6
Renal and cardiovascular protection in type 2 diabetes mellitus: Angiotensin II receptor blockers 6
Advanced glycation end products (Age) and soluble forms of age receptor: Emerging role as mortality risk factors in CKD 6
Mild Renal Dysfunction and Cardiovascular Risk in Hypertensive Patients 6
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 6
Associations Between Cholesterol and Fatty Acid Profile on the Severity of Depression in Older Persons With Nondialysis Chronic Kidney Disease 6
Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress 6
Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress 6
Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice 6
Malnutrition and inflammation are associated with severity of depressive and cognitive symptoms of old patients affected by chronic kidney disease 6
The Number of Medications Is Associated with Fractures in a Population of Dialyzed Older Patients with Frailty 6
The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism 6
Frailty index and adverse outcomes in older patients in haemodialysis 6
MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKD 6
Changes over time in ambulatory blood pressure and cardiac parameters predict cardiovascular outcome of patients with CKD and low cardiovascular morbidity 6
Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5/6 nephrectomized rats 6
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 6
Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship 6
Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease 6
Nutritional Strategies to Prevent Muscle Loss and Sarcopenia in Chronic Kidney Disease: What Do We Currently Know? 6
A new CHA2DS2VASC score integrated with estimated glomerular filtration rate, left ventricular hypertrophy, and pulse pressure is highly effective in predicting adverse cardiovascular outcome in chronic kidney disease 5
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension 5
Frailty in kidney transplantation: a review on its evaluation, variation and long-term impact 5
Calcium carbonate-enriched cheese to improve nutrition, compliance and phosphorus control in patients on kidney replacement therapy 5
Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension 5
Prevention and treatment of diabetic nephropathy: The program for Irbesartan mortality and morbidity evaluation 5
Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease 5
Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: A pilot study 5
Sarcopenia is associated with malnutrition but not with systemic inflammation in older persons with advanced CKD 5
AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease 5
Importance of blood pressure control in chronic kidney disease 4
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 3
Totale 828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.635
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 38 1 6 4 5 5
2021/202232 5 8 6 2 1 5 0 0 2 0 1 2
2022/202357 5 14 9 8 9 7 0 0 2 1 0 2
2023/202414 1 2 2 1 0 5 0 0 2 0 0 1
2024/2025666 1 6 2 2 3 1 15 4 558 74 0 0
Totale 828